Eduardo Lopez-Granados

Dr. Eduardo Lopez-Granados


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
VRVirginia C. Rodríguez-Cortez
Virginia C. Rodríguez-Cortez
LPLucia del Pino-Molina
Lucia del Pino-Molina
JRJavier Rodríguez-Ubreva
Javier Rodríguez-Ubreva
LCLaura Ciudad
Laura Ciudad
DGDavid Gomez-Cabrero
David Gomez-Cabrero
EBEsteban Ballestar
Esteban Ballestar
Common variable immunodeficiency (CVID), the most frequent primary immunodeficiency characterized by loss of B-cell function, depends partly on genetic defects, and epigenetic changes are thought to contribute to its aetiology. Here we perform a high-throughput DNA methylation analysis of this disorder using a pair of CVID-discordant MZ twins and show predominant gain of DNA methylation in CVID B cells with respect to those from the healthy sibling in critical B lymphocyte genes, such as PIK3CD, BCL2L1, RPS6KB2, TCF3 and KCNN4. Individual analysis confirms hypermethylation of these genes. Analysis in naive, unswitched and switched memory B cells in a CVID patient cohort shows impaired ability to demethylate and upregulate these genes in transitioning from naive to memory cells in CVID. Our results not only indicate a role for epigenetic alterations in CVID but also identify relevant DNA methylation changes in B cells that could explain the clinical manifestations of CVID individuals.

24 April 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
LPLucía del Pino-Molina
Lucía del Pino-Molina
JRJavier Rodríguez-Ubreva
Javier Rodríguez-Ubreva
JCJuan Torres Canizales
Juan Torres Canizales
MCMaría Coronel-Díaz
María Coronel-Díaz
MKMarta Kulis
Marta Kulis
ELEduardo Lopez-Granados
Eduardo Lopez-Granados
Common Variable Immunodeficiency (CVID) is characterized by impaired antibody production and poor terminal differentiation of the B cell compartment, yet its pathogenesis is still poorly understood. We first reported the occurrence of epigenetic alterations in CVID by high-throughput methylation analysis in CVID-discordant monozygotic twins. Data from a recent whole DNA methylome analysis throughout different stages of normal B cell differentiation allowed us to design a new experimental approach. We selected CpG sites for analysis based on two criteria: one, CpGs with potential association with the transcriptional status of relevant genes for B cell activation and differentiation; and two, CpGs that undergo significant demethylation from naïve to memory B cells in healthy individuals. DNA methylation was analyzed by bisulfite pyrosequencing of specific CpG sites in sorted naïve and memory B cell subsets from CVID patients and healthy donors. We observed impaired demethylation in two thirds of the selected CpGs in CVID memory B cells, in genes that govern B cell-specific processes or participate in B cell signalling. The degree of demethylation impairment associated with the extent of the memory B cell reduction. The impaired demethylation in such functionally relevant genes as AICDA in switched memory B cells correlated with a lower proliferative rate. Our new results reinforce the hypothesis of altered demethylation during B cell differentiation as a contributing pathogenic mechanism to the impairment of B cell function and maturation in CVID. In particular, deregulated epigenetic control of AICDA could play a role in the defective establishment of a post-germinal center B cell compartment in CVID.

1 January 2019 in Trends in Immunology
Verified
Journal Article
Closed access
ECElena Campos-Sanchez
Elena Campos-Sanchez
JMJorge Martínez-Cano
Jorge Martínez-Cano
LMLucía del Pino Molina
Lucía del Pino Molina
ELEduardo Lopez-Granados
Eduardo Lopez-Granados
ĆCĆesar Cobaleda
Ćesar Cobaleda

17 February 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
LPLucía del Pino-Molina
Lucía del Pino-Molina
ELEduardo Lopez-Granados
Eduardo Lopez-Granados
QLQuentin Lecrevisse
Quentin Lecrevisse
JCJuan Torres Canizales
Juan Torres Canizales
MPMartín Pérez-Andrés
Martín Pérez-Andrés
AOAlberto Orfao
Alberto Orfao
Introduction: Common Variable Immunodeficiency (CVID) is characterized by defective antibody production and hypogammaglobulinemia. Flow cytometry immunophenotyping of blood lymphocytes has become of great relevance for the diagnosis and classification of CVID, due to an impaired differentiation of mature post-germinal-center (GC) class-switched memory B-cells (MBC) and severely decreased plasmablast/plasma cell (Pb) counts. Here, we investigated in detail the pre-GC B-cell maturation compartment in blood of CVID patients.Methods: In this collaborative multicentric study the EuroFlow PID 8-color Pre-GC B-cell tube, standardized sample preparation procedures (SOPs) and innovative data analysis tools, were used to characterize the maturation profile of pre-GC B-cells in 100 CVID patients, vs 62 age-matched healthy donors (HD).Results: The Pre-GC B-cell tube allowed identification within pre-GC B-cells of three subsets of maturation associated immature B-cells and three subpopulations of mature naïve B-lymphocytes. CVID patients showed overall reduced median absolute counts (vs HD) of the two more advanced stages of maturation of both CD5+ CD38+/++ CD21het CD24++ (2.7 vs 5.6 cells/µl, p=0.0004) and CD5+ CD38het CD21+ CD24+ (6.5 vs 17 cells/µl, p<0.0001) immature B cells (below normal HD levels in 22% and 37% of CVID patients). This was associated with an expansion of CD21-CD24- (6.1 vs 0.74 cells/µl, p<0.0001) and CD21-CD24++ (1.8 vs 0.4 cells/µl, p<0.0001) naïve B-cell counts above normal values in 73% and 94% cases, respectively. Additionally, reduced IgMD+ (21 vs 32 cells/µl, p=0.03) and IgMD- (4 vs 35 cells/µl, p1 (CD38, CD5, CD19, CD21, CD24, and/or smIgM) phenotypic marker (57/88 patients; 65%) for a total of 3 distinct CVID patient profiles (group 1: 42/88 patients, 48%; group 2: 8/88, 9%; and group 3: 7/88, 8%) and ii) CVID patients with a clearly altered pre-GC B cell maturation pathway in blood (group 4: 31/88 cases, 35%).Conclusion: Our results show that maturation of pre-GC B-cells in blood of CVID is systematically altered with up to four distinctly altered maturation profiles. Further studies, are necessary to better understand the impact of such alterations on the post-GC defects and the clinical heterogeneity of CVID.

15 January 2020 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
APA. Pérez-Portilla
A. Pérez-Portilla
MMM. Moraru
M. Moraru
ABAlfonso Blázquez-Moreno
Alfonso Blázquez-Moreno
PKPhilipp Kolb
Philipp Kolb
MGMaría Bravo García-Morato
María Bravo García-Morato
Hugh Thomson ReyburnHugh Thomson Reyburn
Hugh Thomson Reyburn

31 August 2021 in Children
Verified
Journal Article
Open access
PDF file
MMMałgorzata Markiewicz-Kijewska
Małgorzata Markiewicz-Kijewska
PKPiotr Kaliciński
Piotr Kaliciński
JTJuan Torres
Juan Torres
AGAngelo Di Giorgio
Angelo Di Giorgio
UBUlrich Baumann
Ulrich Baumann
OGon behalf of ERN TransplantChild Healthcare Working Group
on behalf of ERN TransplantChild Healthcare Working Group
An increasing number of AB0-incompatible (AB0i) liver transplantations (LT) are being undertaken internationally in recent years due to organ shortages and the need for urgent transplantation. The aim of our study was establish the value of ABOi LT from available retrospective results of AB0i pediatric liver transplantations performed in European reference centers now belonging to the TransplantChild, European Reference Network (ERN). Data from medical records were analyzed, including demographic data, diagnosis, urgency of transplantation, time on the waiting list, PELD/MELD score, desensitization procedures, immunosuppression, selected post-transplant complications, and patient and graft survival. A total of 142 patients (pts) with transplants between 1986 and 2018 in 8 European transplant centers were included in the study. The indications for liver transplantation were: cholestatic diseases in 62 pts, acute liver failure in 42 pts, and other conditions in the remaining 38 pts. Sixty-six patients received grafts from living donors, and seventy-six received grafts from deceased donors. Both patient and graft survival were significantly affected by deceased donor type, urgent transplantation, and the development of vascular complications. In the multivariate analysis, vascular complications had a negative impact on patient and graft survival, while a longer time from the first AB0i LT in the study showed better results, suggesting an international learning experience. In conclusion, we believe that AB0i LT in children is now a safe procedure that may be adopted more readily in children.